Join the Colorectal Cancer group to help and get support from people like you.
Colorectal Cancer News (Page 7)
Related terms: Cancer, Anal, Cancer, Colon, Cancer, Colorectal, Cancer, Rectal, Colon Cancer, Colon Carcinoma, Colorectal Carcinoma, Rectal Cancer
Outdoor Pollution Exposure Tied to Nonlung Cancers
THURSDAY, Aug. 10, 2023 – Outdoor air pollution is tied to a higher risk for nonlung cancers in older adults, according to a study published online Aug. 1 in Environmental Epidemiology. Yaguang Wei,...
Breathing Dirty Air Raises Odds for Wide Range of Cancers
WEDNESDAY, Aug. 9, 2023 – New research links air pollution to a variety of cancers, not just lung cancer. Long-term exposure to fine-particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may...
GI Symptoms Persist in Most Female Colorectal Cancer Survivors
WEDNESDAY, Aug. 9, 2023 – Female colorectal cancer (CRC) survivors experience a high burden of gastrointestinal (GI) symptoms, according to a study recently published in PLOS ONE. Claire J. Han,...
Findings of IDEA Collaboration Have Influenced Prescribing Patterns
WEDNESDAY, Aug. 9, 2023 – Changes in prescribing patterns for resected stage III colon cancer have been observed since the abstract presentation of the IDEA collaboration in June 2017, according to...
Time to Treatment Not Tied to Worse Outcomes in Young Colorectal Cancer Patients
TUESDAY, Aug. 8, 2023 – Time from presentation to treatment is not associated with advanced colorectal disease or worse survival in younger patients, according to a study published online Aug. 3 in...
GI Troubles Can Persist for Years in Women Who Survive Colon Cancer
MONDAY, Aug. 7, 2023 – Colon cancer survivors are living longer than ever, but the vast majority of women treated for the disease have lingering gastrointestinal symptoms, such as bloating and gas,...
FDA Approves Lonsurf (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC)
Approval clinical trial showing that treatment with Lonsurf plus bevacizumab resulted in statistically significant and clinically meaningful improvements in overall survival in patients with...
People With Mental Disorders Less Likely to Complete CRC Screening
THURSDAY, Aug. 3, 2023 – People with mental disorders are less likely to participate in colorectal cancer screening versus those without these disorders, according to a study published in the July...
ACP: Screening Average-Risk Adults for Colorectal Cancer Should Start at 50 Years
MONDAY, July 31, 2023 – For asymptomatic average-risk patients, clinicians should start screening for colorectal cancer (CRC) at age 50 years, according to updated guidance from the American College...
Seagen Announces FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer
BOTHELL, Wash.--(BUSINESS WIRE) January 19, 2023 – Seagen Inc. (Nasdaq: SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tukysa (tucatinib)...
FDA Approves Vegzelma (bevacizumab-adcd), a Biosimilar to Avastin
Vegzelma is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA Vegzelma offers U.S. patients living with multiple types of cancer a new, safe, and effective treatment option ...
FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin
BRIDGEWATER, N.J.--(BUSINESS WIRE) April 13, 2022 --Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy
April 8, 2020 - Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for t...
FDA Approves Zirabev (bevacizumab-bvzr), a Biosimilar to Avastin
Friday, June 28, 2019 - Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration(FDA) has approved Zirabev (bevacizumab-bvzr), a biosimilar to...
Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
HENDERSON, Nev.--(BUSINESS WIRE)--Oct. 23, 2018-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a...
Ask a question
To post your own question to this support group, sign in or create an account.